Innova Wealth Partners’s Novo Nordisk NVO Stock Holding History

Innova Wealth Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,337	Closed	-$221K	–	177
2025 Q4	$221K	Buy	4,337 +246	+6%	+$12.6K	0.11%	136
2025 Q3	$227K	Buy	4,091 +1,073	+36%	+$62.8K	0.12%	114
2025 Q2	$208K	Buy	+3,018	New	+$205K	0.12%	101
2024 Q3	–	Sell	-2,037	Closed	-$291K	–	117
2024 Q2	$291K	Buy	+2,037	New	+$270K	0.21%	64

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Innova Wealth Partners's NVO Position: Q1 2026 in Review

Innova Wealth Partners sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,337 shares — an estimated $221K sold.

Innova Wealth Partners first reported a position in NVO in Q2 2024 and held it in 4 quarters. The position peaked at $291K in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Innova Wealth Partners reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Innova Wealth Partners sold 4,337 Novo Nordisk shares in Q1 2026, an estimated $221K.
Innova Wealth Partners first reported a position in Novo Nordisk in Q2 2024 and held it in 4 quarters.
Innova Wealth Partners's Novo Nordisk position peaked at $291K in Q2 2024.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Innova Wealth Partners's 13F filing for Q1 2026, filed 24 Apr 2026.